The 2026 SNMMI annual meeting featured a genitourinary diagnosis and imaging session, including a presentation by Dr. Surekha Yadav discussing longitudinal outcomes of PSMA PET/CT-detected bone ...

(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. David Cade presented LUTEON, an ongoing phase III trial ...

Finally, current quality-of-life tools do not fully capture the patient experience. Emerging approaches incorporating patient ...

Katie Murray discusses non-surgical management options for non-muscle invasive bladder cancer, covering the patient populations where TURBT can be deferred. She identifies recurrent low-grade disease ...

(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. Robert Motzer presented the final analysis of the ...

The 2026 SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kiflom Gebreslassea discussing a longitudinal analysis of estimated glomerular filtration rate ...

Chronic prostatitis/chronic pelvic pain syndrome: Interplay of inflammatory mediators, "Beyond the Abstract," by Dan Lundh, Hans Hedelin, and Dennis Larsson ...

(UroToday.com) The 2026 SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Bryce Tan discussing a study assessing the efficacy of immunological priming of ...

Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...

Dr. Peter O'Donnell presented patient-reported outcomes (PROs) from the phase III KEYNOTE-905/EV-303 trial evaluating perioperative enfortumab vedotin (EV) plus pembrolizumab in cisplatin-ineligible ...

A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell RCC. Treatment options remain ...

The 2026 ASCO annual meeting featured an oral abstract kidney cancer session and a presentation by Dr. Toni Choueiri discussing a ctDNA analysis in participants with renal cell carcinoma (RCC) treated ...